18:35 EST Rain Therapeutics trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on RAIN:
- Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights
- Rain Oncology reports Q3 EPS (19c), consensus (27c)
- Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
- Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
- Rain Oncology confirms receipt of unsolicited proposal from Concentra